Management of Relapsing-Remitting Multiple Sclerosis: Defining the Role of Subcutaneous Recombinant Interferon- -1a (Rebif)

By Lyseng-Williamson K.A.   Plosker G.L.  

Disease Management & Health Outcomes, Vol. 10, Iss. 5, 2002-01 ,pp. : 307-325

Adis International

Access to resources Recommend Favorite

Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study

By Wray Sibyl   Armstrong Robert   Herrman Craig   Calkwood Jonathan   Cascione Mark   Watsky Eric   Hayward Brooke   Mercer Brian   Dangond Fernando  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 12, 2011-12 ,pp. : 1543-1553

Informa Healthcare

Access to resources Recommend Favorite

Smoking and multiple sclerosis susceptibility

By Hedström Anna   Hillert Jan   Olsson Tomas   Alfredsson Lars  

European Journal of Epidemiology, Vol. 28, Iss. 11, 2013-11 ,pp. : 867-874

Springer Publishing Company

Access to resources Recommend Favorite

The cost of hepatitis C and the cost-effectiveness of its prevention

By Shiell A.   Law M.G.  

Health Policy, Vol. 58, Iss. 2, 2001-11 ,pp. : 121-131

Elsevier

Access to resources Recommend Favorite

Impact of Dietary Antigens on Multiple Sclerosis

By Toohey L.  

Journal of Nutritional & Environmental Medicine, Vol. 14, Iss. 4, 2004-12 ,pp. : 319-326

Routledge Ltd

Access to resources Recommend Favorite